| abstract |
The invention relates to antibacterial compounds of formula (I) n n n n n n n n n n wherein n U represents CH or N; W represents CH or N; R 1 represents alkoxy, halogen or CN; ring A represents a pyrrolidin-1,3-diyl-, a piperidin-1,3-diyl or a morpholin-2,4-diyl group and B represents CH 2 ; or ring A is selected from the groups drawn below: n n n n n n n n n n n n wherein R 2 represents H, F or hydroxymethyl, and B is absent; n G represents a group selected from the group consisting of —CH═CH-E, n n n n n n n n n n n n wherein Y 1 , Y 2 , Y 3 and Z independently represent CH or N; Q represents O or S; and E represents phenyl which is mono- or di-substituted wherein the substituents are each independently halogen; n and to pharmaceutically acceptable salts of such compounds. |